SI1926483T1 - Zdravljenje avtoimunskih bolezni - Google Patents

Zdravljenje avtoimunskih bolezni

Info

Publication number: SI1926483T1
Authority: SI; Slovenia
Prior art keywords: autoimmune diseases; treatment; neuritis; uveitis; invention describes
Prior art date: 2005-09-09

Application number

SI200630937T

Other languages

English (en)

Inventor

Rainer Albert

Nigel Graham Cooke

Barbara Nuesslein-Hildesheim

Sven Weiler

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-09

Filing date

2006-09-07

Publication date

2011-04-29

2006-09-07 Application filed by Novartis Ag filed Critical Novartis Ag

2011-04-29 Publication of SI1926483T1 publication Critical patent/SI1926483T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Immunology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SI200630937T 2005-09-09 2006-09-07 Zdravljenje avtoimunskih bolezni SI1926483T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US71599005P	2005-09-09	2005-09-09
EP06793341A EP1926483B1 (en)	2005-09-09	2006-09-07	Treatment of autoimmune diseases
PCT/EP2006/066150 WO2007028821A2 (en)	2005-09-09	2006-09-07	Treatment of autoimmune diseases

Publications (1)

Publication Number	Publication Date
SI1926483T1 true SI1926483T1 (sl)	2011-04-29

Family

ID=37056992

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI200630937T SI1926483T1 (sl)	2005-09-09	2006-09-07	Zdravljenje avtoimunskih bolezni
SI200631889T SI2295049T1 (sl)	2005-09-09	2006-09-07	Zdravljenje avtoimunskih bolezni

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI200631889T SI2295049T1 (sl)	2005-09-09	2006-09-07	Zdravljenje avtoimunskih bolezni

Country Status (28)

Country	Link
US (1)	US20080200438A1 (sl)
EP (2)	EP2295049B1 (sl)
JP (4)	JP5244598B2 (sl)
KR (3)	KR20140117704A (sl)
CN (1)	CN101257899B (sl)
AT (1)	ATE489948T1 (sl)
AU (2)	AU2006289100B2 (sl)
BR (1)	BRPI0615906A2 (sl)
CA (2)	CA2820510A1 (sl)
CY (1)	CY1111285T1 (sl)
DE (1)	DE602006018629D1 (sl)
DK (2)	DK2295049T3 (sl)
ES (2)	ES2357426T3 (sl)
IL (2)	IL189665A (sl)
JO (1)	JO2655B1 (sl)
MA (1)	MA29787B1 (sl)
MX (1)	MX2008003170A (sl)
NO (1)	NO20081727L (sl)
NZ (2)	NZ566137A (sl)
PL (2)	PL2295049T3 (sl)
PT (2)	PT1926483E (sl)
RU (2)	RU2424795C2 (sl)
SG (1)	SG165364A1 (sl)
SI (2)	SI1926483T1 (sl)
TN (1)	TNSN08103A1 (sl)
TW (2)	TWI372620B (sl)
WO (1)	WO2007028821A2 (sl)
ZA (1)	ZA200801694B (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005264431B2 (en) *	2004-07-16	2010-08-19	Kyorin Pharmaceutical Co., Ltd.	Method of effectively using medicine and method concerning prevention of side effect
PT2511262T (pt)	2004-10-12	2017-03-30	Kyorin Seiyaku Kk	Processo para a produção de cloridrato de 2-amino-2-[2-[4-(3- benziloxi-feniltio)-2-clorofenil[etil]-1,3-propanodiol
BRPI0617077A2 (pt) *	2005-10-07	2015-01-06	Kyorin Seiyaku Kk	Agente terapêutico para tratamento de doenças do fígado contendo 2-amina-1, 3-propanediol derivativo como ingrediente ativo, e método para tratamento de doenças do fígado
TWI389683B (zh) *	2006-02-06	2013-03-21	Kyorin Seiyaku Kk	A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
NZ574011A (en) *	2006-08-08	2011-10-28	Kyorin Seiyaku Kk	Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient
CA2659599C (en) *	2006-08-08	2014-06-17	Kyorin Pharmaceutical Co., Ltd.	Amino alcohol derivative and immunosuppressive agent having same as an active ingredient
JP5198293B2 (ja) *	2007-02-13	2013-05-15	杏林製薬株式会社	アミノアルコール誘導体を有効成分とする脱髄性疾患の治療剤又は予防剤
TW200946105A (en)	2008-02-07	2009-11-16	Kyorin Seiyaku Kk	Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient
CN102123735A (zh) *	2008-05-20	2011-07-13	杏林制药株式会社	诱导缓解维持剂
EP2328571B1 (en) *	2008-08-18	2014-06-18	Novartis AG	Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies
AU2011249789B2 (en) *	2010-05-06	2015-03-19	Novartis Ag	Dosage regimen of diaryl sulfide derivatives
KR20130066630A (ko) *	2010-05-06	2013-06-20	노파르티스 아게	자가면역 질환의 치료

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5141421A (en) *	1991-12-17	1992-08-25	Carrier Corporation	Nested coupling mechanism for scroll machines
DE4428835A1 (de) *	1994-08-01	1996-02-08	Schering Ag	Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
CN1178653C (zh) *	1997-02-27	2004-12-08	三菱制药株式会社	药物组合物
AU2002332289B2 (en) *	2001-09-27	2007-05-10	Kyorin Pharmaceutical Co., Ltd.	Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
WO2003029184A1 (en)	2001-09-27	2003-04-10	Kyorin Pharmaceutical Co., Ltd.	Diaryl ether derivative, addition salt thereof, and immunosuppressant
US7482491B2 (en) *	2002-09-19	2009-01-27	Kyorin Pharmaceutical Co., Ltd.	Amino alcohol derivative, addition salt thereof, and immunosuppressant
CN1708293A (zh) *	2002-09-24	2005-12-14	诺瓦提斯公司	治疗脱髓鞘疾病的鞘氨醇－1－磷酸受体激动剂
CA2499977A1 (en) *	2002-09-28	2004-04-08	Mcneil-Ppc, Inc.	Edible solid composition and dosage form
WO2004074297A1 (ja) *	2003-02-18	2004-09-02	Kyorin Pharmaceutical Co., Ltd.	アミノホスホン酸誘導体とその付加塩及びs1p受容体調節剤
NZ592339A (en) *	2003-04-08	2012-09-28	Novartis Ag	Solid pharmaceutical compositions of S1P receptor agonist with sugar alcohol
WO2005014525A2 (en) *	2003-08-12	2005-02-17	Mitsubishi Pharma Corporation	Bi-aryl compound having immunosuppressive activity
MXPA06002349A (es) *	2003-08-28	2006-05-22	Novartis Ag	Derivados de aminopropanol.
AU2005264431B2 (en) *	2004-07-16	2010-08-19	Kyorin Pharmaceutical Co., Ltd.	Method of effectively using medicine and method concerning prevention of side effect
US20090275553A1 (en) *	2004-11-29	2009-11-05	Kovarik John M	Dosage regimen of an s1p receptor agonist
GB0504544D0 (en) *	2005-03-04	2005-04-13	Novartis Ag	Organic compounds

2006
- 2006-09-07 CA CA2820510A patent/CA2820510A1/en not_active Abandoned
- 2006-09-07 DK DK10174280.7T patent/DK2295049T3/en active
- 2006-09-07 RU RU2008113187/15A patent/RU2424795C2/ru not_active IP Right Cessation
- 2006-09-07 PL PL10174280T patent/PL2295049T3/pl unknown
- 2006-09-07 WO PCT/EP2006/066150 patent/WO2007028821A2/en not_active Ceased
- 2006-09-07 JO JO2006298A patent/JO2655B1/en active
- 2006-09-07 EP EP10174280.7A patent/EP2295049B1/en not_active Not-in-force
- 2006-09-07 AT AT06793341T patent/ATE489948T1/de active
- 2006-09-07 SI SI200630937T patent/SI1926483T1/sl unknown
- 2006-09-07 SI SI200631889T patent/SI2295049T1/sl unknown
- 2006-09-07 PT PT06793341T patent/PT1926483E/pt unknown
- 2006-09-07 JP JP2008529636A patent/JP5244598B2/ja active Active
- 2006-09-07 KR KR1020147026128A patent/KR20140117704A/ko not_active Ceased
- 2006-09-07 NZ NZ566137A patent/NZ566137A/en not_active IP Right Cessation
- 2006-09-07 BR BRPI0615906-0A patent/BRPI0615906A2/pt not_active IP Right Cessation
- 2006-09-07 KR KR1020147001496A patent/KR101476591B1/ko not_active Expired - Fee Related
- 2006-09-07 DK DK06793341.6T patent/DK1926483T3/da active
- 2006-09-07 AU AU2006289100A patent/AU2006289100B2/en not_active Ceased
- 2006-09-07 CN CN2006800328984A patent/CN101257899B/zh not_active Expired - Fee Related
- 2006-09-07 EP EP06793341A patent/EP1926483B1/en active Active
- 2006-09-07 PT PT10174280T patent/PT2295049E/pt unknown
- 2006-09-07 ES ES06793341T patent/ES2357426T3/es active Active
- 2006-09-07 DE DE602006018629T patent/DE602006018629D1/de active Active
- 2006-09-07 RU RU2011111117/15A patent/RU2493840C2/ru not_active IP Right Cessation
- 2006-09-07 MX MX2008003170A patent/MX2008003170A/es active IP Right Grant
- 2006-09-07 PL PL06793341T patent/PL1926483T3/pl unknown
- 2006-09-07 NZ NZ588372A patent/NZ588372A/en not_active IP Right Cessation
- 2006-09-07 SG SG201006580-3A patent/SG165364A1/en unknown
- 2006-09-07 ES ES10174280.7T patent/ES2529724T3/es active Active
- 2006-09-07 CA CA2620554A patent/CA2620554C/en not_active Expired - Fee Related
- 2006-09-07 US US12/065,096 patent/US20080200438A1/en not_active Abandoned
- 2006-09-08 TW TW099117063A patent/TWI372620B/zh not_active IP Right Cessation
- 2006-09-08 TW TW095133326A patent/TWI376223B/zh active
2008
- 2008-02-21 ZA ZA200801694A patent/ZA200801694B/xx unknown
- 2008-02-21 IL IL189665A patent/IL189665A/en not_active IP Right Cessation
- 2008-03-06 TN TNP2008000103A patent/TNSN08103A1/en unknown
- 2008-03-17 MA MA30758A patent/MA29787B1/fr unknown
- 2008-04-07 NO NO20081727A patent/NO20081727L/no not_active Application Discontinuation
- 2008-04-08 KR KR1020087008413A patent/KR101476451B1/ko not_active Expired - Fee Related
2010
- 2010-09-21 AU AU2010224355A patent/AU2010224355B2/en not_active Ceased
2011
- 2011-03-01 CY CY20111100242T patent/CY1111285T1/el unknown
2012
- 2012-10-17 JP JP2012230044A patent/JP6077265B2/ja not_active Expired - Fee Related
2014
- 2014-06-23 IL IL233328A patent/IL233328A0/en unknown
- 2014-09-29 JP JP2014199069A patent/JP2015025002A/ja not_active Withdrawn
2016
- 2016-09-30 JP JP2016193400A patent/JP2017019854A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
JP2015025002A (ja)	2015-02-05
CN101257899A (zh)	2008-09-03
JP2017019854A (ja)	2017-01-26
CY1111285T1 (el)	2015-08-05
JO2655B1 (en)	2012-06-17
RU2011111117A (ru)	2012-09-27
NZ588372A (en)	2012-03-30
MX2008003170A (es)	2008-03-18
JP6077265B2 (ja)	2017-02-08
WO2007028821A2 (en)	2007-03-15
DE602006018629D1 (de)	2011-01-13
AU2006289100B2 (en)	2010-07-22
SG165364A1 (en)	2010-10-28
JP2009507810A (ja)	2009-02-26
ZA200801694B (en)	2009-09-30
IL189665A0 (en)	2008-06-05
IL233328A0 (en)	2014-08-31
ES2529724T3 (es)	2015-02-25
JP5244598B2 (ja)	2013-07-24
JP2013010802A (ja)	2013-01-17
BRPI0615906A2 (pt)	2011-05-31
KR20140117704A (ko)	2014-10-07
EP1926483A2 (en)	2008-06-04
EP2295049B1 (en)	2014-11-26
PL1926483T3 (pl)	2011-05-31
SI2295049T1 (sl)	2015-03-31
MA29787B1 (fr)	2008-09-01
RU2493840C2 (ru)	2013-09-27
HK1149906A1 (en)	2011-10-21
US20080200438A1 (en)	2008-08-21
DK1926483T3 (da)	2011-03-14
PT1926483E (pt)	2011-03-03
KR20140019033A (ko)	2014-02-13
EP2295049A1 (en)	2011-03-16
KR101476591B1 (ko)	2014-12-24
WO2007028821A3 (en)	2007-05-03
AU2010224355A1 (en)	2010-10-14
NZ566137A (en)	2011-05-27
ATE489948T1 (de)	2010-12-15
KR20080046231A (ko)	2008-05-26
RU2008113187A (ru)	2009-10-20
RU2424795C2 (ru)	2011-07-27
CA2620554C (en)	2013-12-17
ES2357426T3 (es)	2011-04-26
TWI372620B (en)	2012-09-21
TW201034659A (en)	2010-10-01
PL2295049T3 (pl)	2015-04-30
AU2010224355B2 (en)	2012-03-29
PT2295049E (pt)	2015-03-02
CN101257899B (zh)	2012-10-03
EP1926483B1 (en)	2010-12-01
AU2006289100A1 (en)	2007-03-15
NO20081727L (no)	2008-06-06
TNSN08103A1 (en)	2009-07-14
CA2820510A1 (en)	2007-03-15
KR101476451B1 (ko)	2014-12-24
CA2620554A1 (en)	2007-03-15
TWI376223B (en)	2012-11-11
DK2295049T3 (en)	2015-02-23
IL189665A (en)	2014-07-31
TW200803829A (en)	2008-01-16

Publication	Publication Date	Title
IL233328A0 (en)	2014-08-31	Treatment of autoimmune diseases
TW200509892A (en)	2005-03-16	Novel aminobenzophenone compounds
WO2005032471A3 (en)	2005-07-07	Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007022470A3 (en)	2007-06-14	Methods and compositions for treating neurological disease
WO2006058868A8 (de)	2007-01-18	Substituierte pteridine zur behandlung von entzündlichen erkrankungen
TW200806325A (en)	2008-02-01	Therapeutic uses of inhibitors of RTP801
WO2005051914A8 (en)	2005-08-11	Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
MX2011012015A (es)	2012-04-30	Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer.
PL1910338T3 (pl)	2011-02-28	Związki heterotetracykliczne jako mimetyki TPO
WO2006058867A3 (de)	2006-10-26	Substituierte pteridine zur behandlung von entzündlichen erkrankungen
UA90698C2 (en)	2010-05-25	Triazole substituted aminobenzophenone compounds
WO2009136997A3 (en)	2009-12-30	Inhibitors of human cathepsin l, cathepsin b, and cathepsin s
TW200635597A (en)	2006-10-16	Substituted pteridines for the treatment of inflammatory diseases
WO2006078576A3 (en)	2006-10-05	Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
MX2008002166A (es)	2008-04-22	Compuestos y composiciones como mimeticos de trombopoietina (tpo).
BR0306855A (pt)	2005-04-05	Método para o tratamento de distúrbios cognitivos
WO2007058862A3 (en)	2007-10-11	Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
TW200633711A (en)	2006-10-01	Substituted pteridines for the treatment of inflammatory diseases
IL181713A0 (en)	2008-03-20	Use of il-17f for the treatment and/or prevention of neurological diseases
WO2007019080A3 (en)	2008-01-17	Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
TW200603791A (en)	2006-02-01	Compounds and compositions as cathepsin S inhibitors
CY1116051T1 (el)	2017-02-08	Θεραπεια αυτοανοσων ασθενειων
TW200628453A (en)	2006-08-16	Triazole substituted aminobenzophenone compounds
BRPI0402756A (pt)	2006-02-21	método para o tratamento de distúrbios cognitivos
MX2007003281A (es)	2007-05-18	N-etilhidroxietilamina util en el tratamiento de afecciones del sistema nervioso central.